Interleukin 6 and Clinical Parameters in Malignant Pleural Mesothelioma
Author Information
Author(s): T Nakano, AP Chahinian, M Shinjo, A Tonomura, M Miyake, N Togawa, K Ninomiya, K Higashino
Primary Institution: Hyogo College of Medicine
Hypothesis
What is the relationship between interleukin 6 levels and clinical parameters in patients with malignant pleural mesothelioma?
Conclusion
Malignant mesothelioma patients have high levels of interleukin 6 in pleural fluid that leak into the systemic circulation and induce clinical inflammatory reactions.
Supporting Evidence
- Serum levels of interleukin 6 were significantly higher in mesothelioma than in lung adenocarcinoma.
- 48% of mesothelioma patients exhibited thrombocytosis.
- IL-6 levels in pleural fluid were significantly higher in mesothelioma patients compared to those with adenocarcinoma.
Takeaway
This study found that patients with a type of lung cancer called malignant pleural mesothelioma have a lot of a substance called interleukin 6 in their body, which can cause inflammation.
Methodology
Serum and pleural fluid samples were obtained from patients and analyzed for interleukin 6 and other proteins using ELISA kits.
Limitations
The study does not establish a specific diagnostic criterion for differentiating mesothelioma from adenocarcinoma.
Participant Demographics
25 patients with malignant pleural mesothelioma, 17 with lung adenocarcinoma, and 15 with tuberculous pleurisy.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website